DLGAP1-AS1

Across TCGA pan-cancer cohorts, DLGAP1-AS1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated DLGAP1-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DLGAP1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DLGAP1-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

KIRC, BRCA, and ACC are the cancer types where DLGAP1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.830	0.912	.003	76	view →
BRCA	OS	Tertile	All	0.654	0.538	<.001	76	view →
ACC	DFS	Median	All	0.226	0.671	<.001	69	view →
LGG	DFS	Median	All	0.623	0.836	<.001	54	view →
UVM	OS	Median	III,IV	0.604	0.948	.002	52	view →
LUAD	OS	Quartile	All	0.716	0.906	.003	36	view →
UCS	OS	Median	IV	0.752	0.404	.013	32	view →
GBM	DFS	Tertile	All	0.170	0.331	.007	30	view →
OV	OS	Median	All	0.366	0.279	.008	26	view →
MESO	DFS	Tertile	All	0.482	0.299	.014	25	view →
LAML	DFS	Tertile	All	0.412	0.716	.009	24	view →
SARC	OS	Quartile	All	0.937	0.750	<.001	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

DLGAP1-AS1–KIRC (DFS)

Open the KIRC breakdown →